• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型天然 GRAS 级肠溶包衣,适用于医药和营养保健品。

A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products.

机构信息

Drug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames, London, United Kingdom.

Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, United Kingdom.

出版信息

Int J Pharm. 2020 Jun 30;584:119392. doi: 10.1016/j.ijpharm.2020.119392. Epub 2020 May 4.

DOI:10.1016/j.ijpharm.2020.119392
PMID:32376448
Abstract

In this study, enteric coatings based exclusively on naturally occurring ingredients were reported. Alginate (Alg) and pectin (Pec) blends with or without naturally occurring glyceride, glycerol monostearate (GMS), were initially used to produce solvent-casted films. Incorporating GMS in the natural polymeric films significantly enhanced the acid-resistance properties in gastric medium. Theophylline tablets coated with Alg-Pec blends without GMS disintegrated shortly after incubation in gastric medium (pH 1.2), leading to a premature and complete release of theophylline. Interestingly, tablets coated with Alg-Pec blends that contain the natural glyceride (GMS) resisted the gastric environment for 2 h with minimal drug release (<5%) and disintegrated rapidly following introduction to the intestinal medium, allowing a fast and complete drug release. Furthermore, the coating system proved to be stable for six months under accelerated conditions. These findings are particularly appealing to nutraceutical industry as they provide the foundation to produce naturally-occurring GRAS based enteric coatings.

摘要

在这项研究中,报告了完全基于天然成分的肠溶包衣。藻酸盐(Alg)和果胶(Pec)与或不与天然甘油酯、单硬脂酸甘油酯(GMS)混合,最初用于制备溶剂浇铸薄膜。在天然聚合物薄膜中加入 GMS 显著提高了在胃酸介质中的耐酸性。用不含 GMS 的 Alg-Pec 混合物包衣的茶碱片在胃介质(pH 1.2)中孵育后很快崩解,导致茶碱过早且完全释放。有趣的是,用含有天然甘油酯(GMS)的 Alg-Pec 混合物包衣的片剂在胃环境中抵抗 2 小时,药物释放量最小(<5%),并在引入肠道介质后迅速崩解,使药物快速完全释放。此外,该涂层系统在加速条件下经过六个月的时间仍保持稳定。这些发现对营养保健品行业特别有吸引力,因为它们为生产天然、GRAS 肠溶性包衣提供了基础。

相似文献

1
A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products.一种新型天然 GRAS 级肠溶包衣,适用于医药和营养保健品。
Int J Pharm. 2020 Jun 30;584:119392. doi: 10.1016/j.ijpharm.2020.119392. Epub 2020 May 4.
2
Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.医药和营养保健品用 GRAS 级肠溶包衣的耐胃肠特性。
Int J Pharm. 2015;486(1-2):167-74. doi: 10.1016/j.ijpharm.2015.03.039. Epub 2015 Mar 18.
3
An innovative wax-based enteric coating for pharmaceutical and nutraceutical oral products.一种创新的蜡基肠溶包衣,用于医药和营养保健品的口服产品。
Int J Pharm. 2020 Dec 15;591:119935. doi: 10.1016/j.ijpharm.2020.119935. Epub 2020 Oct 1.
4
Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline.用于茶碱结肠给药的肠溶包衣果胶基骨架片的研制。
J Drug Target. 2003 Jul;11(6):365-71. doi: 10.1080/10611860310001639130.
5
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery.用于结肠给药的肠溶果胶酸钙微球的研制。
Eur J Pharm Biopharm. 2008 Jun;69(2):508-18. doi: 10.1016/j.ejpb.2007.12.004. Epub 2007 Dec 15.
6
Alginate-magnesium aluminum silicate films: effect of plasticizers on film properties, drug permeation and drug release from coated tablets.海藻酸盐-镁铝硅酸盐薄膜:增塑剂对薄膜性能、药物渗透及包衣片药物释放的影响
Int J Pharm. 2007 Mar 21;333(1-2):34-44. doi: 10.1016/j.ijpharm.2006.09.046. Epub 2006 Sep 30.
7
A Novel Alginate Film Based on Nanocoating Approach for Enteric-Release Tablets.基于纳米涂层方法的新型海藻酸盐薄膜用于肠溶片剂。
AAPS PharmSciTech. 2023 Apr 6;24(4):99. doi: 10.1208/s12249-023-02557-0.
8
Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.工艺参数和处方因素对用尤特奇L 100-55包衣的片剂药物释放的影响。
Eur J Pharm Biopharm. 2007 Sep;67(2):464-75. doi: 10.1016/j.ejpb.2007.02.021. Epub 2007 Mar 7.
9
Self-emulsifying excipient platform for improving technological properties of alginate-hydroxypropylcellulose pellets.用于改善海藻酸钠-羟丙基纤维素微丸技术性能的自乳化辅料平台
Int J Pharm. 2016 Feb 29;499(1-2):74-80. doi: 10.1016/j.ijpharm.2015.12.048. Epub 2015 Dec 22.
10
Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.茶碱片的干粉用 Eudragit E PO 和 Eudragit L 100-55 包衣的性质。
Pharm Dev Technol. 2009;14(6):632-41. doi: 10.3109/10837450902882369.

引用本文的文献

1
Glycosaminoglycans' Ability to Promote Wound Healing: From Native Living Macromolecules to Artificial Biomaterials.糖胺聚糖促进伤口愈合的能力:从天然生物大分子到人工生物材料。
Adv Sci (Weinh). 2024 Mar;11(9):e2305918. doi: 10.1002/advs.202305918. Epub 2023 Dec 10.
2
Microencapsulation by a Spray Drying Approach to Produce Innovative Probiotics-Based Products Extending the Shelf-Life in Non-Refrigerated Conditions.喷雾干燥法微囊化生产创新益生菌产品,延长非冷藏条件下的保质期。
Molecules. 2023 Jan 15;28(2):860. doi: 10.3390/molecules28020860.
3
Biomaterials for Tissue Engineering Applications and Current Updates in the Field: A Comprehensive Review.
组织工程应用中的生物材料及该领域的最新进展:全面综述。
AAPS PharmSciTech. 2022 Sep 26;23(7):267. doi: 10.1208/s12249-022-02419-1.
4
A Novel Multilayer Natural Coating for Fed-State Gastric Protection.一种用于进食状态下胃保护的新型多层天然涂层。
Pharmaceutics. 2022 Jan 26;14(2):283. doi: 10.3390/pharmaceutics14020283.
5
Optimization and Preliminary Physicochemical Characterization of Pectin Extraction from Watermelon Rind () with Citric Acid.用柠檬酸从西瓜皮中提取果胶的优化及初步理化特性研究
Int J Food Sci. 2022 Jan 6;2022:3068829. doi: 10.1155/2022/3068829. eCollection 2022.
6
The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.胶囊内胶囊组合对人体志愿者体内崩解的影响:一项联合成像与唾液示踪剂研究。
Pharmaceutics. 2021 Nov 25;13(12):2002. doi: 10.3390/pharmaceutics13122002.